Duration of Dual Antiplatelet Therapy After Coronary Stent Insertion: Does the Benefit of Extended Therapy Outweigh the Risk?

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2017 Jun 30

PMID 28661872

Authors

Aleta Schellenberg

Danielle Shmyr

Karolina Koziol

Brian Martens

Lynette Kosar

Affiliations

Soon will be listed here.

References

Kim B, Hong M, Shin D, Nam C, Kim J, Ko Y . A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol. 2012; 60(15):1340-8. DOI: 10.1016/j.jacc.2012.06.043. View

Bhatt D, Fox K, Hacke W, Berger P, Black H, Boden W . Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354(16):1706-17. DOI: 10.1056/NEJMoa060989. View

Roffi M, Patrono C, Collet J, Mueller C, Valgimigli M, Andreotti F . 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed). 2015; 68(12):1125. DOI: 10.1016/j.rec.2015.10.009. View

Bhatt D, Flather M, Hacke W, Berger P, Black H, Boden W . Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007; 49(19):1982-8. DOI: 10.1016/j.jacc.2007.03.025. View

Navarese E, Andreotti F, Schulze V, Kolodziejczak M, Buffon A, Brouwer M . Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials. BMJ. 2015; 350:h1618. PMC: 4410620. DOI: 10.1136/bmj.h1618. View

Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N . Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol. 2014; 64(20):2086-97. DOI: 10.1016/j.jacc.2014.09.008. View

Schulz-Schupke S, Byrne R, Ten Berg J, Neumann F, Han Y, Adriaenssens T . ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J. 2015; 36(20):1252-63. DOI: 10.1093/eurheartj/ehu523. View

Abraham N, Hlatky M, Antman E, Bhatt D, Bjorkman D, Clark C . ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and.... J Am Coll Cardiol. 2010; 56(24):2051-66. DOI: 10.1016/j.jacc.2010.09.010. View

Bonaca M, Bhatt D, Cohen M, Steg P, Storey R, Jensen E . Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372(19):1791-800. DOI: 10.1056/NEJMoa1500857. View

10.

Gwon H, Hahn J, Park K, Song Y, Chae I, Lim D . Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation. 2011; 125(3):505-13. DOI: 10.1161/CIRCULATIONAHA.111.059022. View

11.

Verdoia M, Schaffer A, Barbieri L, Montalescot G, Collet J, Colombo A . Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials. Angiology. 2015; 67(3):224-38. DOI: 10.1177/0003319715586500. View

12.

Levine G, Bates E, Bittl J, Brindis R, Fihn S, Fleisher L . 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update.... Circulation. 2016; 134(10):e123-55. DOI: 10.1161/CIR.0000000000000404. View

13.

Lee C, Ahn J, Park D, Kang S, Lee S, Kim Y . Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Circulation. 2013; 129(3):304-12. DOI: 10.1161/CIRCULATIONAHA.113.003303. View

14.

Gilard M, Barragan P, Noryani A, Noor H, Majwal T, Hovasse T . 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. J Am Coll Cardiol. 2014; 65(8):777-786. DOI: 10.1016/j.jacc.2014.11.008. View

15.

Giustino G, Baber U, Sartori S, Mehran R, Mastoris I, Kini A . Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2015; 65(13):1298-1310. DOI: 10.1016/j.jacc.2015.01.039. View

16.

Cassese S, Byrne R, Ndrepepa G, Schunkert H, Fusaro M, Kastrati A . Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials. Clin Res Cardiol. 2015; 104(10):887-901. DOI: 10.1007/s00392-015-0860-1. View

17.

Spencer F, Prasad M, Vandvik P, Chetan D, Zhou Q, Guyatt G . Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med. 2015; 163(2):118-26. DOI: 10.7326/M15-0083. View

18.

Abo-Salem E, Alsidawi S, Jamali H, Effat M, Helmy T . Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials. Cardiovasc Ther. 2015; 33(5):253-63. DOI: 10.1111/1755-5922.12137. View

19.

Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F . Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet. 2015; 385(9985):2371-82. DOI: 10.1016/S0140-6736(15)60263-X. View

20.

Collet J, Silvain J, Barthelemy O, Range G, Cayla G, Van Belle E . Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet. 2014; 384(9954):1577-85. DOI: 10.1016/S0140-6736(14)60612-7. View